Cerebral amyloid angiopathy, subcortical white matter disease and dementia: Literature review and study in OPTIMA

Brain Pathology

Volumn 25, Issue 1, 2015, Pages 51-62

  Esiri, Margaret ^a   Chance, Steven ^a   Joachim, Catharine ^a   Warden, Donald ^b   Smallwood, Aidan ^c   Sloan, Carolyn ^a   Christie, Sharon ^d   Wilcock, Gordon ^d   Smith, A David ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Alzheimer's disease; ApoE; CAA; cerebral white matter; dementia

Indexed keywords

ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN ANTIBODY; AMYLOID BETA VACCINE; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; UNCLASSIFIED DRUG; VACCINE;

AGED; ALLELE; BLOOD VESSEL INJURY; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT; CONFERENCE PAPER; DEMENTIA; DISEASE ASSOCIATION; FEMALE; GENETIC RISK; GENOTYPE; HUMAN; MALE; NEUROIMAGING; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW (TOPIC); TISSUE INJURY; VASCULAR AMYLOIDOSIS; WHITE MATTER LESION; ANIMAL; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; COMPLICATION; GENETICS; LEUKOENCEPHALOPATHY; LONGITUDINAL STUDY; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANIMALS; APOLIPOPROTEINS E; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; DEMENTIA; FEMALE; HUMANS; LEUKOENCEPHALOPATHIES; LONGITUDINAL STUDIES; MALE;

EID: 84923326516     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12221     Document Type: Conference Paper

References (130)

1. Arbel-Ornath M, Hudry E, Eikermann-Haerter K, Hou S, Gregory JL, Zhao L, et al (2013) Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models. Acta Neuropathol 126: 353-364.
2. Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA, (2011) Cerebral amyloid angiopathy, pathology and cognitive domains in older persons. Ann Neurol 69: 320-327.
3. Attems J, Jellinger KA, (2014) Pathologic aspects of the haemorrhagic consequences of small vessel disease on the brain. In: Cerebral Small Vessel Disease., L Pantoni, PB Gorelick, (eds), pp. 29-41. Cambridge Univ Press: Cambridge.
4. Attems J, Jellinger K, Thal DR, Nostrand W, (2011) Review: sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 37: 75-93.
5. Bachmeier C, Paris D, Beaulieu-Abdelahad D, Mouzon B, Mullan M, Crawford F, (2013) A multifaceted role for apoE in the clearance of beta-Amyloid across the blood-brain barrier. Neurodegener Dis 11: 13-21.
6. Bachmeier C, Shackleton B, Ojo J, Paris D, Mullan M, Crawford F, (2014) Apolipoprotein E isoform-specific effects on lipoprotein receptor processing. Neuromolecular Med 868-696. doi: 10.1007/s12017-014-8318-6.
7. Bangen K, Nation D, Clark L, Harmeli A, Wierenga C, Dev S, et al (2014) Interactive effects of vascular risk burden and advanced age on cerebral blood flow. Front Aging Neurosci 6: 159.
8. Barakos J, Sperling R, Salloway S, Jack C, Gass A, Fiebach JB, et al (2013) MR imaging features of amyloid-related imaging abnormalities. AJNR Am J Neuroradiol 48: 244-248.
9. Beitzke M, Gattringer T, Enzinger C, Wagner G, Niederkorn K, Fazekas F, (2011) Clinical presentation, etiology and long term prognosis in patients with non-traumatic convexal subarachnoid haemorrhage. Stroke 42: 3055-3060.
10. Bell RD, Sagare AP, Friedman AE, Bedi GS, Holtzman DM, Deane R, Zlokovic BV, (2007) Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow and Metab 27: 909-918.
11. Biffi A, Sonni A, Anderson CD, Kissela B, Jagiella J, Schmidt H, (2010) Variants at ApoE influence risk of deep and lobar intracerebral haemorrhage. Ann Neurol 68: 934-943.
12. Biffi A, Anderson CD, Jagiella JM, Schmidt J, Kissela B, Hansen B, (2011) APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study. Lancet Neurol 10: 702-709.
13. Boche D, Zotova E, Weller RO, Love S, Neal JW, Pickering RM, et al (2008) Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. Brain 131: 3299-3310.
14. Braak H, Braak E, (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82: 239-259.
15. Cadavid D, Mena H, Koeller K, Frommelt RA, (2000) Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction: a case control study in human brain biopsies. J Neuropathol Exp Neurol 59: 768-773.
16. Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold K-H, et al (1999) Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA 96: 14088-14093.
17. Carare RO, Hawkes CA, Jeffrey M, Kalaria RN, Weller RO, (2013) Cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination protein results in prominent deposition of cerebrovascular amyloid. Neuropathol Appl Neurobiol 39: 593-611.
18. Chalmers K, Wilcock GK, Love S, (2003) APOEe4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of Ab protein. Neuropathol Appl Neurobiol 29: 231-238.
19. Chalmers K, Wilcock GK, Love S, (2005) Contributors to white matter damage in the frontal lobe in Alzheimer's disease. Neuropathol Appl Neurobiol 31: 623-631.
20. Charimidou A, Werring DJ, (2011) Cerebral microbleeds: detection, mechanisms and clinical challenges. Future Neurol 6: 587-611.
21. Charimidou A, Gang Q, Werring DJ, (2012) Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry 83: 124-137.
22. Charimidou A, Jaunmuktane Z, Baron J-C, Burnell M, Varlet P, Peeters A, et al (2014) White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy? Neurology 82: 57-62.
23. Chen YW, Gurol ME, Rosand J, Viswanathan A, Rakich SM, Groover TR, et al (2006) Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology 67: 83-87.
24. Chung KK, Anderson NE, Hutchinson D, Synek B, Barber PA, (2011) Cerebral amyloid angiopathy related inflammation: three case reports and a review. J Neurol Neurosurg Psychiatry 82: 20-26.
25. Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, et al (2008) apoE isoform-specific disruption of amyloid β peptide clearance from mouse brain. J Clin Invest 118: 4002-4013.
26. Deramecourt V, Slade JY, Oakley AE, Perry RH, Ince PG, Maurage CA, Kalaria RN, (2012) Staging and natural history of cerebrovascular pathology in dementia. Neurology 78: 1043-1050.
27. Dierksen GA, Skehan ME, Khan MA, Jeng J, Nandigam RN, Becker JA, et al (2010) Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann Neurol 68: 545-548.
28. Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, Heyman A, (1996) Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, part XV. Neurology 46: 1592-1596.
29. Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM, (2004) Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 55: 250-256.
30. Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, et al (2000) Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 59: 23-30.
31. Esiri MM, Joachim C, Sloan C, Christie S, Agacinski G, Bridges LR, et al (2014) Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer's disease: a clinicopathologic study in the Oxford project to Investigate Memory and Ageing (OPTIMA). Alzheimer Dis Assoc Disord 28: 35-40.
32. Feldman HH, Maia LF, Mackenzie IR, Forster BB, Martzke J, Woolfenden A, (2008) Superficial siderosis: a potential diagnostic marker of cerebral amyloid angiopathy in Alzheimer disease. Stroke 39: 2894-2897.
33. Ferrer I, Boada Rovira M, Sánchez Guerra ML, Rey MJ, Costa-Jussá F, (2004) Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease. Brain Pathol 14: 11-20.
34. Ferriero JA, Ansbacher LE, Vinters HV, (1989) Stroke related to cerebral amyloid angiopathy: the significance of systemic vascular disease. J Neurol 236: 267-272.
35. Fryer JD, Taylor JW, DeMattos RB, Bales KR, Paul SM, Parsadanian M, Holtzman DM, (2003) Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous haemorrhage in amyloid precursor protein transgenic mice. J Neurosci 23: 7889-7896.
36. Fryer JD, Simmons K, Parsadanian M, Bales KR, Paul SM, Sullivan PM, Holtzman DM, (2005) Human apolipoprotein E4 alters the amyloid-β 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. J Neurosci 25: 2803-2810.
37. Gorelick PB, Scuteri A, Black SE, DeCarli C, Greenberg SM, Iadecola C, et al (2011) Vascular contributions to cognitive impairment and dementia. A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42: 2672-2713.
38. Gray F, Dubas F, Roullet E, Escourolle R, (1985) Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol 18: 54-59.
39. Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Isla T, Hyman BT, (1995) Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 50: 961-965.
40. Greenberg SM, Vonsattel JP, Segal AZ, Chiu RI, Clatworthy AE, Liao A, et al (1998) Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology 50: 961-965.
41. Greenberg SM, Gurol E, Rosand J, Smith EE, (2004a) Amyloid angiopathy-related vascular cognitive impairment. Stroke 35: 2616-2619.
42. Greenberg SM, Eng JA, Ning M, Smith EE, Rosand J, (2004b) Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke 35: 1415-1420.
43. Greenberg SM, Grabowski T, Gurol E, Skehan ME, Nandigam K, Becker JA, et al (2008) Detection of isolated cerebrovascular β-Amyloid with Pittsburgh compound B. Ann Neurol 64: 587-591.
44. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi S, Warach S, Launer LJ, (2009) Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 8: 165-174.
45. Gregoire SM, Charimidou A, Gadapa N, Dolan E, Nagui A, Peeters A, et al (2011) Acute ischaemic brain lesions in intracerebral haemorrhage: multicentre cross-sectional magnetic resonance imaging study. Brain 134: 2376-2386.
46. Grinberg LT, Thal DR, (2010) Vascular pathology in the aged human brain. Acta Neuropathol 119: 277-290.
47. Gurol ME, Irizarry MC, Smith EE, Raju S, Diaz-Arrastia R, Bottiglieri T, et al (2006) Plasma β-Amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 66: 23-29.
48. Gurol ME, Viswanathan A, Gidicsin C, Hedden T, Martinez-Ramirez S, Dumas A, et al (2013) Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. Ann Neurol 73: 529-536.
49. Haglund M, Englund E, (2002) Cerebral amyloid angiopathy, white matter lesions and Alzheimer encephalopathy-A histopathological assessment. Dement Geriatr Cogn Disord 14: 161-166.
50. Haglund M, Kalaria R, Slade JY, Englund E, (2006) Differential deposition of amyloid b peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia. Acta Neuropathol 111: 430-435.
51. Hawkes C, Sullivan PM, Hands S, Weller RO, Nicoll JAR, Carare RO, (2012) Disruption of arterial perivascular drainage of amyloid b from the brains of mice expressing the human APOE e4 allele. PLoS ONE 7: e41636.
52. Heier LA, Bauer CJ, Schwartz L, Zimmerman RD, Morgello S, Deck MD, (1989) Large Virchow-Robin spaces: MR-clinical correlation. AJNR Am J Neuroradiol 10: 929-936.
53. Holland CM, Smith EE, Csapo I, Gurol ME, Brylka DA, Killiany RJ, et al (2008) Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy and healthy aging. Stroke 39: 1127-1133.
54. Jellinger KA, (2002) Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 109: 813-836.
55. Johnson KA, Gregas M, Becker JA, Kinnecom C, Salat DH, Moran EK, et al (2007) Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol 62: 229-234.
56. Keage HAD, Carare RO, Friedland RP, Ince PG, Love S, Nicoll JA, et al (2009) Population studies of sporadic amyloid angiopathy and dementia: a systematic review. BMC Neurol 9: 3.
57. Kidwell CS, Greenberg SM, (2009) Red meets white: do microbleeds link hemorrhagic and ischemic crebrovascular disease? Neurology 73: 1614-1615.
58. Kim J, Jiang H, Park S, Eltorai AEM, Stewart FR, Yoon H, et al (2011) Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid β amyloidosis. J Neurosci 31: 18007-18012.
59. Kinnecom C, Lev MH, Wendell L, Smith EE, Rosand J, Frosch MP, Greenberg SM, (2007) Course of cerebral amyloid angiopathy-related inflammation. Neurology 68: 1411-1416.
60. Knudsen KA, Rosand J, Karluk D, Greenberg SM, (2001) Clinical diagnosis of cerebral amyloid angiopathy: validation of Boston criteria. Neurology 56: 537-539.
61. Linn J, Halpin A, Demaerel P, Ruhland J, Giese AD, Dichgans M, et al (2010) Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 74: 1346-1350.
62. Liu C-C, Kanakiyo T, Xu H, Bu G, (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9: 106-118.
63. Lockhart A, Lamb JR, Osredkar T, Sue LI, Joyce JN, Ye L, et al (2007) PIB is a non-specific imaging marker of amyloid-beta (Ab) peptide-related cerebral amyloidosis. Brain 130: 2607-2615.
64. Love S, Chalmers K, Ince P, Esiri M, Attems J, Jellinger K, et al (2014) Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post mortem brain tissue. Am J Neurodegener Dis 3: 19-32.
65. Lovelock CE, Cordonnier C, Naka H, Salman RA, Sudlow CLM,. (2010) Antithrombotic drug use, cerebral microbleeds, and intracerebral haemorrhage: a systematic review of published and unpublished studies. Stroke 41: 1222-1228.
66. Ly JV, Donnan GA, Villemagne VL, Zavala JA, Ma H, O'Keefe G, et al (2010) 11 C-PIB binding is increased in patients with cerebral amyloid angiopathy-related haemorrhage. Neurology 74: 487-493.
67. Mahley RW, Huang Y, (2009) Alzheimer disease: multiple causes, multiple effects of apolipoprotein E4, and multiple therapeutic approaches. Ann Neurol 65: 623-625.
68. Mahley RW, Huang Y, (2012) Apolipoprotein E sets the stage: response to injury triggers neuropathology. Neuron 76: 871-885.
69. Martel CL, Mackic JB, Matsubara E, Governale S, Miguel C, Miao W, et al (1997) Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta. J Neurochem 69: 1995-2004.
70. Martinez-Ramirez S, Pontes-Neto OM, Dumas AP, Auriel E, Halpin A, Quimby M, et al (2013) Topography of dilated perivascular spaces in subjects from a memory clinic cohort. Neurology 80: 1551-1556.
71. McCarron MO, Nicoll JA, Stewart J, Ironside JW, Mann DMA, Love S, et al (1999) The apolipoprotein E ε2 allele and the pathological features in cerebral amyloid angiopathy-related cerebral hemorrhage. J Neuropathol Exp Neurol 58: 711-718.
72. Miners JS, Van Helmond Z, Chalmers K, Wilcock G, Love S, Kehoe PG, (2006) Decreased expression and activity of neprilysin in Alzheimer's disease are associated with cerebral amyloid angiopathy. J Neuropathol Exp Neurol 65: 1012-1021.
73. Mirra SS, (1997) The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary. Neurobiol Aging 18 (Suppl. 4): S91-S94.
74. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al (1991) The consortium to establish a registry for Alzheimer's disease (CERAD) part II standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486.
75. Montaner J, (2011) Genetics of intracerebral haemorrhage: a tsunami effect of ApoEε2 genotype on brain bleeding size? Lancet Neurol 10: 673-675.
76. MRC-CFAS (2001) Pathological correlates of late-onset dementia in a multicentre community-based population in England and Wales. Lancet 357: 169-175.
77. Nakata-Kudo Y, Mizuno T, Yamada K, Shiga K, Yoshikawa K, Mori S, et al (2006) Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease. Dement Geriatr Cogn Disord 22: 8-14.
78. Nelson PT, Pious NM, Jicha GA, Wilcock DM, Fardo DW, Estus S, Rebeck GW, (2013) APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature. J Neuropathol Exp Neurol 72: 708-715.
79. Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO, (2003) Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 9: 448-452.
80. O'Donnell HC, Rosand J, Knudsen KA, Furie KL, Segal AZ, Chiu RI, et al (2000) Apolipoprotein E genotype and the risk of recurrent lobar intracerebral haemorrhage. New Engl J Med 342: 240-245.
81. Okamoto Y, Yamamoto T, Kalaria RN, Senzaki H, Maki T, Hase Y, et al (2012) Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts. Acta Neuropathol 123: 381-394.
82. Olichney JM, Hansen LA, Hofstetter CR, Grundman M, Katzman R, Thal LJ, (1995) Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 52: 702-708.
83. Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R, Thal LJ, (1996) The apolipoprotein E e4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 47: 190-196.
84. Peca S, McCreary CR, Donaldson E, Kumarpillai G, Shobha N, Sanchez K, et al (2013) Neurovascular decoupling is associated with severity of cerebral amyloid angiopathy. Neurology 81: 1659-1665.
85. Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ, (2002) Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology 58: 1629-1634.
86. Piazza F, Greenberg SM, Savoiardo M, Gardinetti M, Chiapparini L, Raicher I, et al (2013) Anti-Amyloid b autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies. Ann Neurol 73: 449-458.
87. Plant GT, Ghiso J, Holton JL, Frangione B, Revesz T, (2004) Familial and sporadic cerebral amyloid angiopathies associated with dementia and the BRI dementias. In: The Neuropathology of Dementia, 2nd edn., MM Esiri, VM-Y Lee, JQ Trojanowski, (eds), pp. 330-352. Cambridge University Press: Cambridge.
88. Potter H, Wisniewski T, (2012) Apolipoprotein E: essential catalyst of the Alzheimer amyloid cascade. Int J Alzheimers Dis 2012: 489428.
89. Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN, (1996) Apolipoprotein E-epsilon 4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 148: 2083-2095.
90. Rannikmae K, Samarasekera N, Martînez-Gonzâlez NA, Salman RA, Sudlow CLM, (2013) Genetics of cerebral amyloid angiopathy: systematic review and meta-Analysis. J Neurol Neurosurg Psychiatry 84: 901-908.
91. Rannikmae K, Kalaria RN, Greenberg SM, Chui HC, Schmitt FA, Samarasekera N, et al (2014) APOE associations with severe CAA-Associated vasculopathic changes: collaborative meta-Analysis. J Neurol Neurosurg Psychiatry 85: 300-305.
92. Raposo N, Viguier A, Cuvinciuc V, (2011) Cortical subarachnoid haemorrhage in the elderly: a recurrent event probably related to cerebral amyloid angiopathy. Eur J Neurol 18: 597-603.
93. Revesz T, Holton JL, Lashley T, Plant G, Rostagno A, Ghiso J, Frangione B, (2002) Sporadic and familial cerebral amyloid angiopathies. Brain Pathol 12: 343-357.
94. Revesz T, Holton JL, Lashley T, Plant G, Frangione B, Rostagno A, Ghiso J, (2009) Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol 118: 115-130.
95. Rigby H, Easton A, Bhan V, (2011) Amyloid-β related angiitis of the central nervous system: report of 3 cases. Can J Neurol Sci 38: 626-630.
96. Ritter MA, Droste DW, Hegedus K, Szepesi R, Nabavi DG, Csiba L, Ringelstein EB, (2005) Role of cerebral amyloid angiopathy in intracerebral haemorrhage in hypertensive patients. Neurology 64: 1233-1237.
97. Roher AE, Kuo Y-M, Esh C, Knebel C, Weiss N, Kalback W, et al (2003) Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol Med 9: 112-1296.
98. Roob G, Lechner A, Schmidt R, Flooh E, Hartung HP, Fazekas F, (2000) Frequency and location of microbleeds in patients with primary intracerebral haemorrhage. Stroke 31: 2665-2669.
99. Roth M, Huppert F, Tim E, Mountjoy QC, (1988) CAMDEX: The Cambridge Examination for Mental Disorders in the Elderly. Cambridge University Press: Cambridge.
100. Sadowski M, Pankiewicz J, Scholtzova H, Ripellino JA, Li YS, Schmidt SD, et al (2004) A synthetic peptide blocking the apolipoprotein E/β-Amyloid binding mitigates β-Amyloid toxicity and fibril formation in vitro and reduces β-Amyloid plaques in transgenic mice. Am J Pathol 165: 937-948.
101. Sadowski MJ, Pankiewicz J, Scholtzova H, Mehta PD, Prelli F, Quartermain D, Wisniewski T, (2006) Blocking the apolipoprotein E/amyloid-β interaction as a potential therapeutic approach for Alzheimer's disease. Proc Natl Acad Sci USA 103: 18787-18792.
102. Salat DH, Smith EE, Tuch DS, Benner T, Pappu V, Schwab KM, et al (2006) White matter alterations in cerebral amyloid angiopathy measured by diffusion tensor imaging. Stroke 37: 1759-1764.
103. Scholz W, (1938) Studienzurpathologiederhirngefabell: die drusige entartung der hirnarterien und capillaren. Gesamte Neurol Psychiatry 162: 694-715.
104. Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J, et al (2005) Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 128: 500-515.
105. Seo SW, Lee BH, Kim E-J, Chin J, Cho YS, Yoon U, Na DL, (2007) Clinical significance of microbleeds in subcortical vascular dementia. Stroke 38: 1949-1951.
106. Smallwood A, Oulhaj A, Joachim C, Christie C, Sloan C, Smith AD, Esiri M, (2012) Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: a pathological study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort. Neuropathol Appl Neurobiol 38: 337-343.
107. Spagnuolo MS, Maresca B, La Marca V, Carrizzo A, Veronesi C, Cupidi C, et al (2014) Haptoglobin interacts with apolipoprotein E and beta amyloid and influences their crosstalk. ACS Chem Neurosci 5: 837-847.
108. Suddath TL, Weekman EM, Brothers HM, Braun K, Wilcock DM, (2014) β-Amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice. Alzheimers Res Ther 6: 32.
109. Thal DR, Ghebremedhin E, Rub U, Yamaguchi H, DelTredici K, Braak H, (2002) Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol 61: 282-293.
110. Thal DR, Ghebrenedhin E, Orantes M, Wiestler OD, (2003) Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol 62: 1287-1301.
111. Thal DR, Grinberg LT, Attems J, (2012) Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain. Exp Gerontol 47: 816-824.
112. Tian J, Shi J, Bailey K, Mann DMA, (2004) Relationships between arteriosclerosis, cerebral amyloid angiopathy and myelin loss from cerebral cortical white matter in Alzheimer's disease. Neuropathol Appl Neurobiol 30: 46-56.
113. Tomimoto H, Akiguchi I, Akiyama H, Ikeda K, Wakita H, Lin JX, Budka H, (1999) Vascular changes in white matter lesions of Alzheimer's disease. Acta Neuropathol 97: 629-634.
114. van Swieten JC, Geyskes GG, Derix MM, Peeck BM, Ramos LM, van Latum JC, van Gijn J, (1991) Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol 30: 825-830.
115. Verghese PB, Castellano JM, Holtzman DM, (2011) Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol 10: 241-252.
116. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen WJ, Hofman A, et al (2008) Prevalence and risk factors of cerebral microbleeds: the Rotterdam scan study. Neurology 70: 1208-1214.
117. Vinters HV, Ellis WG, Zarow C, Zaias BW, Jagust WJ, Mack WJ, Chui HC, (2000) Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol 59: 931-945.
118. Viswanathan A, Greenberg SM, (2011) Cerebral amyloid angiopathy in the elderly. Ann Neurol 70: 871-880.
119. Viswanathan A, Patel P, Rahman R, Nandigam RNK, Kinnecom C, Bracoud L, et al (2008) Tissue microstructural changes are independently associated with cognitive impairment in cerebral amyloid angiopathy. Stroke 39: 1988-1992.
120. von Sattel PG, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP Jr, (1991) Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 30: 637-639.
121. Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE, (1998) Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 153: 725-733.
122. Weller RO, Subash M, Preston SD, Mazanti I, Carare RO, (2008) Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol 18: 253-266.
123. Weller RO, Boche D, Nicholl JAR, (2009) Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta Neuropathol 118: 87-102.
124. Werring DJ, Sperling R, (2013) Inflammatory cerebral amyloid angiopathy and amyloid-modifying therapies: variations on the same ARIA? Ann Neurol 73: 439-441.
125. Xu D, Yang C, Wang L, (2003) Cerebral amyloid angiopathy in aged Chinese: a clinico-neuropathological study. Acta Neuropathol 106: 89-91.
126. Xu F, Grande AM, Robinson JK, Previti ML, Davis J, Van Nostrand WE, (2007) Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioural deficits in vasculotropic mutant amyloid beta-protein precursor transgenic mice. Neuroscience 146: 98-107.
127. Yates PA, Desmond PM, Phal PM, Steward C, Szoeke C, Salvado O, et al (2014) Incidence of cerebral microbleeds in preclinical Alzheimer's disease. Neurology 82: 1266-1273.
128. Zago W, Schroeter S, Guido T, Khan K, Seubert P, Yednock T, et al (2013) Vascular alterations in PDAPP mice after anti-Ab immunotherapy: implications for amyloid-related imaging abnormalities. Alzheimers Dement 9: S105-S115.
129. Zhu D, Zhu YY, Chabriat H, Godin O, Dufouil C, Rosand J, et al (2012) Distribution of white matter hyperintensity in cerebral hemorrhage and healthy aging. J Neurol 259: 530-536.
130. Zlokovic BV, (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12: 723-737.